Quote | Defence Therapeutics Inc Cl A (OTCMKTS:DTCFF)
Last: | $0.9779 |
---|---|
Change Percent: | 0.0% |
Open: | $0.9779 |
Close: | $0.9779 |
High: | $0.9779 |
Low: | $0.9779 |
Volume: | 750 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | Defence Therapeutics Inc Cl A (OTCMKTS:DTCFF)
Vancouver, British Columbia--(Newsfile Corp. - May 14, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) (" Defence " or the " Company "), a Canadian biopharmaceutical company developing novel immune-oncology vaccines and drug delivery technologies, is pleased to announce the...
Vancouver, British Columbia--(Newsfile Corp. - May 1, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC), (" Defence " or the " Company "), a Canadian biopharmaceutical company developing novel immune-oncology therapeutics and drug delivery technologies, is pleased to announce...
Message Board Posts | Defence Therapeutics Inc Cl A (OTCMKTS:DTCFF)
Subject | By | Source | When |
---|---|---|---|
Why are there no trades here ? Thank | Man6677 | investorshub | 01/26/2022 2:44:28 PM |
Get in $KITL .08-.10 news will be poppin | newspopper | investorshub | 10/03/2021 4:39:21 PM |
Need more volume for Poppin action | newspopper | investorshub | 10/03/2021 4:37:55 PM |
Looking for FDA Poppin news | newspopper | investorshub | 10/03/2021 4:36:35 PM |
$KITL news going to be poppin | newspopper | investorshub | 10/03/2021 4:35:32 PM |
News, Short Squeeze, Breakout and More Instantly...
Defence Therapeutics Inc Cl A Company Name:
DTCFF Stock Symbol:
OTCMKTS Market:
Vancouver, British Columbia--(Newsfile Corp. - May 14, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) (" Defence " or the " Company "), a Canadian biopharmaceutical company developing novel immune-oncology vaccines and drug delivery technologies, is pleased to announce the...
Vancouver, British Columbia--(Newsfile Corp. - May 1, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC), (" Defence " or the " Company "), a Canadian biopharmaceutical company developing novel immune-oncology therapeutics and drug delivery technologies, is pleased to announce...
Vancouver, British Columbia--(Newsfile Corp. - April 23, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) (" Defence " or the " Company "), a Canadian biopharmaceutical company developing novel immune-oncology therapeutics and drug delivery technologies, is pleased to announ...